In this context, nmMLCK inhibition, with two inhibitors acting through two different mechanisms, prevents IL-6 secretion downstream of p65-NFκB activation, the increase of transendothelial migration and the endothelial dysfunction in aortas induced by IH. This evidence concerns the gene NFKB1 and isolated hemihyperplasia.